The Global Radiation Oncology Devices Market to Upsurge at a CAGR of ~8% by 2027 | DelveInsight

News provided by

Jan 30, 2023, 10:30 ET

Rising cancer cases, rapid technological development activities, strong R&D initiatives from key players, rising adoption of radiotherapy procedures in cancer treatment, and increasing demand for minimally invasive procedures are all contributing to the radiation oncology devices market growth during the forecast period.

LAS VEGAS, Jan. 30, 2023 /PRNewswire/ -- DelveInsight's Radiation Oncology Devices Market Insights report provides the current and forecast market analysis, individual leading radiation oncology devices companies' market shares, challenges, radiation oncology devices market drivers, barriers, and trends, and key radiation oncology devices companies in the market.

Key Takeaways from the Radiation Oncology Devices Market Report

As per DelveInsight estimates, North America is anticipated to dominate the global radiation oncology devices market during the forecast period.
Notable radiation oncology devices companies such as Siemens Healthineers AG, Elekta AB, Accuray Incorporated, IBA Worldwide, C. R. Bard, Inc (BD), Isoray Inc., Mevion Medical Systems, Viewray Technologies, Inc., Eckert & Ziegler BEBIG, ZEISS, GT Medical Technologies, Inc., Hitachi, Ltd., Xoft (iCAD, Inc.), IntraOp Medical, Inc., Panacea Medical Technologies Pvt. Ltd., SIT - S.I.T. Sordina IORT Technologies S.p.A., Sensus Healthcare, Inc., Theragenics, Optivus Proton Therapy, Inc., P-cure, and several others are currently operating in the radiation oncology devices market.
In Jan 2023, Accuray Incorporated announced that Auckland Radiation Oncology (ARO) is the first facility in New Zealand to use the CyberKnife® System, a robotic radiation therapy device known for delivering treatments with sub-millimeter precision and accuracy in 1 to 5 outpatient sessions.
On January 5, 2023, ViewRay, Inc. announced that Chindex Medical Limited (Chindex), through its subsidiary, has ordered 10 MRIdian MR-Guided Therapy Systems.
In November 2022, Elekta announced the FDA 510(k) clearance of Elekta Esprit, a new Leksell Gamma Knife radiosurgery platform.
In October 2022, CIVCO Radiotherapy, a global provider of radiotherapy solutions, announced a partnership with Qfix, a provider of patient positioning and immobilization devices.
In June 2022, Varian announced today that it had received an IDE from the FDA to advance its Flash clinical research program.
In February 2022, GT Medical Technologies Inc., creators of GammaTile Therapy, announced its 2021 roster of ELITE Distinguished Brain Tumor Specialists that have completed 10 or more GammaTile Therapy procedures in 2021.

To read more about the latest highlights related to the radiation oncology devices market, get a snapshot of the key highlights entailed in the Global Radiation Oncology Devices Market Report

Radiation Oncology Devices Overview

Radiation therapy (RT) uses high-energy X-rays or other particles to destroy tumor cells. It is used to slow or stop tumor growth and is usually given after surgery, and may be combined with chemotherapy. The most common type of radiation treatment is external-beam radiation therapy, which delivers radiation from a machine outside the body. Internal radiation therapy, also known as brachytherapy, is the delivery of radiation therapy through implants.

Radiation Oncology Devices Market Insights

Among all regions, North America is expected to account for the largest share of the global radiation oncology devices market. Rising cancer prevalence, supportive government policies, increased emphasis on promoting oncology research, and a favorable environment for product development and launch will drive the region's radiation oncology devices market growth.

Furthermore, the increased emphasis on product development activities and device manufacturers' eagerness to enter local markets contribute to the expansion of regional radiation oncology device markets. For example, Alpha Tau's alpha-radiation cancer therapy breakthrough device designation was granted by the US Food and Drug Administration (FDA) in October 2021 to treat patients with recurrent glioblastoma multiforme (GBM).

These types of product launches in local markets drive demand for radiation oncology devices in the market. The North American radiation oncology devices market is expected to grow during the forecast period due to the interaction of various factors, such as the presence of a large patient population, encouraging reimbursement policies, and new product launches in the region.

To know more about why North America is leading the market growth in the radiation oncology devices market, get a snapshot of the Radiation Oncology Devices Market Outlook

Radiation Oncology Devices Market Dynamics

The radiation oncology devices market is experiencing increased product demand for a variety of reasons; one of which is the rising prevalence of various cancers. Radiation oncology devices are in high demand in the field of medical imaging these days. Radiation oncology devices are an effective imaging technique that aids physicians in diagnosing cancers in the brain, prostate, lung, and other organs.

However, the high costs of procedures and the side effects associated with radiation may be limiting factors in the growth of the radiation oncology devices market.

Furthermore, outpatient visits were canceled due to the pandemic, as were non-emergency hospitals and procedures. As a result, the number of routine clinical examinations and related procedures for visits was reduced.

However, the development of the COVID-19 vaccine has started the process of economic recovery, with the easing of lockdown restrictions and the return of normalcy in the economic landscape, which has started the process of resumption of regular healthcare services such as outpatient visits, thereby increasing demand in the radiation oncology devices market.

Get a sneak peek at the radiation oncology devices market dynamics @ Radiation Oncology Devices Market Dynamics Analysis

Report Metrics	Details
Coverage	Global
Study Period	2019–2027
Base Year	2021
Radiation Oncology Devices Market CAGR	~8%
Key Radiation Oncology Devices Companies	Siemens Healthineers AG, Elekta AB, Accuray Incorporated, IBA Worldwide, C. R. Bard, Inc (BD), Isoray Inc., Mevion Medical Systems, Viewray Technologies, Inc., Eckert & Ziegler BEBIG, ZEISS, GT Medical Technologies, Inc., Hitachi, Ltd., Xoft (iCAD, Inc.), IntraOp Medical, Inc., Panacea Medical Technologies Pvt. Ltd., SIT - S.I.T. Sordina IORT Technologies S.p.A., Sensus Healthcare, Inc., Theragenics, Optivus Proton Therapy, Inc., P-cure, among others

Radiation Oncology Devices Market Assessment

Radiation Oncology Devices Market Segmentation

Market Segmentation By Type: External Beam Radiation Therapy [Linear Accelerators (Linac), Stereotactic Advanced Electron/Cobalt-60 Linear Accelerators {Gamma Knife, Cyberknife, Tomotherapy}, Proton Therapy, Cyclotron, Synchrotron, Others], Internal Beam Radiotherapy/Brachytherapy
Market Segmentation By Technology: External Beam Radiation Therapy [Image-Guided Radiotherapy (Igrt), Intensity Modulated Radiotherapy (Imrt), Stereotactic Technology, Proton Beam Therapy, 3D Conformal Radiotherapy (3D CRT), Others], Internal Beam Radiotherapy/Brachytherapy [Low-Dose Rate Brachytherapy, High-Dose Rate Brachytherapy]
Market Segmentation By Application: External Beam Radiation Therapy (Prostate Cancer, Breast Cancer, Lung Cancer, Head And Neck Cancer, Colorectal Cancer, Others), Internal Beam Radiation Therapy (Prostate Cancer, Gynecological Cancer, Breast Cancer, Cervical Cancer, Penile Cancer, Others)
Market Segmentation By End User: Hospitals, Independent Radiotherapy Centers, Others
Market Segmentation By Geography: North America, Europe, Asia-Pacific, and Rest of World

Porter's Five Forces Analysis, Product Profiles, Case Studies, KOL's Views, Analyst's View

Which MedTech key players in the radiation oncology devices market are set to emerge as the trendsetter explore @ Radiation Oncology Devices Companies

Table of Contents

1	Report Introduction
2	Executive summary
3	Regulatory and Patent Analysis
4	Key Factors Analysis
5	Porter's Five Forces Analysis
6	COVID-19 Impact Analysis on Radiation Oncology Devices Market
7	Radiation Oncology Devices Market Layout
8	Global Company Share Analysis – Key 3-5 Companies
9	Radiation Oncology Devices Market Company and Product Profiles
10	Project Approach
11	About DelveInsight

Interested in knowing the radiation oncology devices market by 2027? Click to get a snapshot of the Radiation Oncology Devices Market Trends

Related Reports

Cancer Therapy Market

Cancer Therapy Market Insight, Competitive Landscape, and Market Forecast – 2027 report delivers an in-depth understanding of market trends, market drivers, market barriers, and key cancer therapy companies, including GlaxoSmithKline, Eli Lilly & Company, F. Hoffmann-La Roche Ltd, AbbVie Inc., Amgen Inc, Sanofi, among others.

Intratumoral Cancer Therapies Market

Intratumoral Cancer Therapies Market Insight, Epidemiology, and Market Forecast – 2032 report delivers an in-depth understanding of market trends, market drivers, market barriers, along with emerging drugs and key intratumoral cancer therapies companies, including Daiichi Sankyo, Amgen, Idera Pharmaceuticals, Philogen, among others.

Oncology Drugs Market

Oncology Drugs Market Insight, Competitive Landscape, and Market Forecast – 2027 report delivers an in-depth understanding of market trends, market drivers, market barriers, and key oncology drugs companies, including GlaxoSmithKline, Eli Lilly & Company, F. Hoffmann-La Roche Ltd, among others.

Intratumoral Cancer Therapies Market

Intratumoral Cancer Therapies Market Insight, Epidemiology, and Market Forecast – 2032 report delivers an in-depth understanding of market trends, market drivers, market barriers, and key intratumoral cancer therapies companies, including Daiichi Sankyo, Amgen, Idera Pharmaceuticals, among others.

Liquid Biopsy in Cancer Diagnostics Market

Liquid Biopsy in Cancer Diagnostics Market Insight, Competitive Landscape, and Market Forecast – 2027 report delivers an in-depth understanding of market trends, market drivers, market barriers, and key liquid biopsy in cancer diagnostics companies, including Myriad Genetics Inc, Exact Sciences Corporation, Biocartis, Sysmex Corporation, among others.

Other Trending Reports

Related Healthcare Blogs

Upcoming Oncological Drugs in 2022

Metastatic Castration-Sensitive Prostate Cancer Treatment Market

Related Cases Studies

Competitive Intelligence

Market Assessment

Product Assessment

Epidemiology Assessment

Related Healthcare Services

Healthcare Consulting

Healthcare Competitive Intelligence Services

Healthcare Asset Prioritization Services

About DelveInsight

DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports pharma companies by providing comprehensive end-to-end solutions to improve their performance. Get hassle-free access to all the healthcare and pharma market research reports through our subscription-based platform PharmDelve.

Connect with us on LinkedIn|Facebook|Twitter

Additionally, get in touch with our business executive to explore @Healthcare Due Diligence Services

Contact Us

Shruti Thakur
[email protected]
+1(919)321-6187
https://www.delveinsight.com/medical-devices

Logo: https://mma.prnewswire.com/media/1082265/DelveInsight_Logo.jpg

SOURCE DelveInsight Business Research, LLP